Who Prescribes and Oversees the Switch?
Switch from Ozempic (semaglutide 0.25mg, 0.5mg, 1mg, 2mg pens) to Wegovy (semaglutide 0.25mg up to 2.4mg pens) only under doctor supervision. Both are weekly subcutaneous injections from Novo Nordisk for type 2 diabetes (Ozempic) or chronic weight management (Wegovy). Self-switching risks dosing errors or side effects; consult your prescriber for BMI eligibility, as Wegovy targets obesity (BMI ≥30 or ≥27 with comorbidities).
Standard Transition Protocol
No washout period needed—semaglutide has a ~1-week half-life, so overlap is safe if timed right.
- Same starting dose: If on Ozempic 0.25mg, 0.5mg, or 1mg weekly, start Wegovy at the same dose next injection day.[1]
- Higher Ozempic doses: If on 2mg Ozempic, start Wegovy at 1.7mg (or nearest available), then titrate up.[1][2]
- Titration schedule (Wegovy-specific to minimize nausea/vomiting):
| Week | Dose |
|------|---------------|
| 1-4 | 0.25mg |
| 5-8 | 0.5mg |
| 9-12 | 1mg |
| 13-16| 1.7mg |
| 17+ | 2.4mg |
Match your current Ozempic dose to this ladder; increase every 4 weeks as tolerated.[1]
Inject on the same day each week, with or without food. Use new pens—Ozempic and Wegovy pens differ in dosing increments.
What If You're Already at Max Ozempic?
Patients on Ozempic 2mg often switch for higher Wegovy 2.4mg weight loss potential. Drop to Wegovy 1.7mg initially, then go to 2.4mg after 4 weeks if no issues. Clinical data shows ~15% more weight loss on 2.4mg vs. 1mg semaglutide.[3]
Common Side Effects During Transition
Expect similar GI issues (nausea 44%, diarrhea 30%, vomiting 24% at higher doses). They peak during dose escalations—hydrate, eat small meals, avoid fatty foods. Rare risks: pancreatitis, gallbladder issues, thyroid tumors (boxed warning). Monitor blood sugar if diabetic.[1][2]
Why Switch and When to Expect Results?
Switch for greater weight loss (Wegovy trials: 15-17% body weight vs. Ozempic's 10-15% in diabetes studies). Effects build over 68 weeks; track via app or doctor visits. Insurance may cover Wegovy better for obesity.[4]
Cost and Access Differences
Ozempic: ~$936/month without insurance. Wegovy: ~$1,349/month, but NovoCare savings cards cap at $25/month for eligible patients (up to 13 fills).[5] Check coverage—Wegovy shortages eased in 2024, but verify pharmacy stock.
Alternatives If Switch Isn't Ideal